Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
We described recently a subacute serum autoantibody response toward glial fibrillary acidic protein (GFAP) and its breakdown products 5–10 days after severe traumatic brain injury (TBI). Here, we expanded our anti-GFAP autoantibody (AutoAb[GFAP]) investigation to the multicenter observational study Transforming Research and Clinical Knowledge in TBI Pilot (TRACK-TBI Pilot) to cover the full spectrum of TBI (Glasgow Coma Scale 3–15) by using acute (<24 h) plasma samples from 196 patients with acute TBI admitted to three Level I trauma centers, and a second cohort of 21 participants with chronic TBI admitted to inpatient TBI rehabilitation. We find that acute patients self-reporting previous TBI with loss of consciousness (LOC) ( n = 43) had higher day 1 AutoAb[GFAP] (mean ± standard error: 9.11 ± 1.42; n = 43) than healthy controls (2.90 ± 0.92; n = 16; p = 0.032) and acute patients reporting no previous TBI (2.97 ± 0.37; n = 106; p < 0.001), but not acute patients reporting previous TBI without LOC (8.01 ± 1.80; n = 47; p = 0.906). These data suggest that while exposure to TBI may trigger the AutoAb[GFAP] response, circulating antibodies are elevated specifically in acute TBI patients with a history of TBI. AutoAb[GFAP] levels for participants with chronic TBI (average post-TBI time 176 days or 6.21 months) were also significantly higher (15.08 ± 2.82; n = 21) than healthy controls ( p < 0.001). These data suggest a persistent upregulation of the autoimmune response to specific brain antigen(s) in the subacute to chronic phase after TBI, as well as after repeated TBI insults. Hence, AutoAb[GFAP] may be a sensitive assay to study the dynamic interactions between post-injury brain and patient-specific autoimmune responses across acute and chronic settings after TBI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic neuropathologies of single and repetitive TBI: substrates of dementia?
Smith, D. H., Johnson, V. E., & Stewart, W. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.29 · Cited by 699
Neuronal autoantigens—pathogenesis, associated disorders and antibody testing
Lancaster, E., & Dalmau, J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.99 · Cited by 512
Papa, L., Lewis, L. M., Falk, J. L., Zhang, Z., Silvestri, S., Giordano, P., Brophy, G. M., Demery, J. A., Dixit, N. K., Ferguson, I., et al. (2012) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.08.021 · Cited by 332
Self-citationZhang, Z., Zoltewicz, J. S., Mondello, S., Newsom, K. J., Yang, Z., Yang, B., Kobeissy, F., Guingab, J., Glushakova, O., Robicsek, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092698 · Cited by 200 · cited 5×
“We previously demonstrated that post-TBI serum AutoAb[GFAP] shows a delayed increase, beginning about 5–6 days after severe TBI and sustained to at least 10 days.(26,38) Here, we”
BackgroundMethodResultSelf-citationAdd Alzheimer's disease to the list of autoimmune diseases
D’Andrea, M. R. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.024 · Cited by 113
Tanriverdi, F., De Bellis, A., Battaglia, M., Bellastella, G., Bizzarro, A., Sinisi, A. A., Bellastella, A., Unluhizarci, K., Selcuklu, A., Casanueva, F. F., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-1024 · Cited by 108
Cited by
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Abdelhak, A., Foschi, M., Abu-Rumeileh, S., Yue, J. K., D’Anna, L., Huss, A., Oeckl, P., Ludolph, A. C., Kuhle, J., Petzold, A., et al. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00616-3 · Cited by 807
Self-citationAn update on diagnostic and prognostic biomarkers for traumatic brain injury
Wang, K. K., Yang, Z., Zhu, T., Shi, Y., Rubenstein, R., Tyndall, J. A., & Manley, G. T. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1428089 · Cited by 542
Self-citationCellular infiltration in traumatic brain injury
Alam, A., Thelin, E. P., Tajsic, T., Khan, D. Z., Khellaf, A., Patani, R., & Helmy, A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02005-x · Cited by 297
Pathophysiology of Traumatic Brain Injury
McGinn, M. J., & Povlishock, J. T. (2016) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2016.06.002 · Cited by 262
Rubenstein, R., Chang, B., Yue, J. K., Chiu, A., Winkler, E. A., Puccio, A. M., Diaz-Arrastia, R., Yuh, E. L., Mukherjee, P., Valadka, A. B., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0655 · Cited by 260
Self-citationBiomarkers in Moderate to Severe Pediatric Traumatic Brain Injury: A Review of the Literature
Munoz Pareja, J. C., Li, X., Gandham, N., Wang, K. K., Lautenslager, L., Pareja, M. C., Shanmugham, P., Faulkinberry, S., Ghosh, S., Kerrigan, M., et al. (2022) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2022.03.002 · Cited by 27
Self-citationAdaptive Immune Responses Associated with the Central Nervous System Pathology of Gulf War Illness
Nkiliza, A., Joshi, U., Evans, J. E., Ait-Ghezala, G., Parks, M., Crawford, F., Mullan, M., & Abdullah, L. (2021) · Neuroscience Insights · doi:10.1177/26331055211018458 · Cited by 15
Metadata
- Authors
- Wang, K. K. W., Yang, Z., Yue, J. K., Zhang, Z., Winkler, E. A., Puccio, A. M., Diaz-Arrastia, R., Lingsma, H. F., Yuh, E. L., Mukherjee, P., Valadka, A. B., Gordon, W. A., Okonkwo, D. O., Manley, G. T., and the TRACK-TBI Investigators (including, Cooper, S. R., Dams-O'Connor, K., Hricik, A. J., Inoue, T., Maas, A. I. R., Menon, D. K., Schnyer, D. M., Sinha, T. K., & Vassar, M. J.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 2016-07
- Volume
- 33
- Issue
- 13
- Pages
- 1270-1277
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W2179071311
- Cited by
- 85
- References
- 6
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.